Li-Weber and colleagues at the German Cancer Research Center (DKFZ) have demonstrated that several benzofuran flavaglines prevent tumor growth and sensitize resistant cancer cells to apoptosis by blocking the Raf-MEK (mitogen and extracellular-signal regulated protein kinase)-ERK (extracellular-signal regulated protein kinase) signaling pathway. The gene discussed is MAP2K7; the disease is cancer.